The government has announced it will invest £133m in new technology for the NHS, including tools for arthritis and cancer diagnosis, as well as gene-based therapies for diseases including dementia. The fund will be spread across several different areas of treatment, including £50m ring-fenced for NHS diagnostics services and for supporting Centres of Excellence in digital pathology and imaging with artificial intelligence. Adult social care will receive £7.5m over eight years, which will fund research to improve care delivery. A project dedicated to developing new therapies for genetic mutations, including those linked to Parkinson's and cancer, will receive £30m over four years. A further £14m will also be spent on bioscience projects across the UK.